Aspen has delivered double-digit earnings growth, despite a challenging trading environment characterised by inflationary cost pressures.
The pharmaceutical firm has reported a 31% increase in annual headline earnings per share and has hiked its dividend by 24% to R3.26. Business Day TV unpacked the results with Stephen Saad.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: